Edesa Biotech (EDSA) Capital Expenditures (2013 - 2022)
Edesa Biotech's Capital Expenditures came in at -$41.00 for fiscal Q4 2022 (quarter ended Sep 30, 2022), compared with -$1,464 a year earlier.
Powered by 
Analysis
Edesa Biotech (EDSA) Capital Expenditures (2013 - 2022) Analysis & Trends
For FY2022 (ended Sep 30, 2022), Edesa Biotech's Capital Expenditures was $5,656, down 8.0% from FY2021.
- Capital Expenditures carries a five-year compound annual growth rate of -54.9% (FY2017 to FY2022).
- Going back by fiscal year, Capital Expenditures was $6,146 in FY2021 (-79.2%), $29,483 in FY2020 (+264.2%), $8,095 in FY2019 (-97.9%) and $382,810 in FY2018 (+26.5%).
- The five-year range for quarterly Capital Expenditures is -$1,464 (fiscal Q4 2021) to $171,124 (fiscal Q2 2018).
- Year-over-year, Capital Expenditures increased in two of the last four quarters, with growth averaging 78.7%.
- The fastest year-over-year change in Capital Expenditures over five years came in fiscal Q2 2018 (growth of 303.1%), and the weakest in fiscal Q3 2018 (a decline of 90.7%).
- Business Quant data shows EDSA's Capital Expenditures at $1,358 (Q3 2022), $1,199 (Q2 2022) and $3,140 (Q1 2022) in the three fiscal quarters before Q4 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 1.32 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 321.00 Mn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 1.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 533.00 Mn |
| 10 | Edesa Biotech | 26.08 Mn | -19.46 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2022 | -41.00 |
| Jun 30, 2022 | 1,358.00 |
| Mar 31, 2022 | 1,199.00 |
| Dec 31, 2021 | 3,140.00 |
| Sep 30, 2021 | -1,464.00 |
| Jun 30, 2021 | 3,512.00 |
| Mar 31, 2021 | 2,963.00 |
| Dec 31, 2020 | 1,135.00 |
| Sep 30, 2020 | 4,031.00 |
| Mar 31, 2020 | 825.00 |
| Dec 31, 2018 | 5,666.00 |
| Sep 30, 2018 | 21,410.00 |
| Jun 30, 2018 | 155,509.00 |
| Mar 31, 2018 | 171,124.00 |
| Dec 31, 2017 | 34,767.00 |
| Sep 30, 2017 | 102,368.00 |
| Jun 30, 2017 | 73,489.00 |
| Mar 31, 2017 | 42,452.00 |
| Dec 31, 2016 | 84,424.00 |
| Sep 30, 2016 | 107,413.00 |
API Access
Edesa Biotech Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=EDSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "EDSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=EDSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();